List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 147 studies with search of: "Hemophilia A"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting Study of a Recombinant Protein-Free Factor VIII (rAHF-PFM): Comparison of Continuous Infusion Versus Intermittent Bolus Infusion in Hemophilia A Subjects Undergoing Unilateral Knee Replacement
Condition: Hemophilia A
Intervention: Drug: Recombinant Protein-Free Factor VIII (rAHF-PFM)
2 Completed Study of Pharmacokinetics, Efficacy, and Safety of a Recombinant and Protein-Free Factor VIII (rAHF-PFM) in Pediatric Patients With Hemophilia A
Condition: Hemophilia A
Intervention: Drug: Antihemophilic factor, recombinant, manufactured protein-free
3 Completed Efficacy and Safety Study of a Recombinant Protein-Free Manufactured Factor VIII (rAHF-PFM) in Previously Untreated Hemophilia A Patients
Condition: Hemophilia A
Intervention: Drug: Antihemophilic factor, recombinant, manufactured protein-free (rAHF-PFM)
4 Terminated Trial of Rituximab Versus Oral Cyclophosphamide to Eradicate or Suppress Autoimmune Anti-Factor VIII Antibodies in Acquired Hemophilia A
Condition: Hemophilia A
Interventions: Drug: Rituxan;   Drug: prednisone
5 Completed Efficacy and Safety Study of a Recombinant and Protein-Free Factor VIII (rAHF-PFM) in Pediatric Patients in Canada With Hemophilia A - A Continuation of Baxter Study 060101
Condition: Hemophilia A
Intervention: Drug: Antihemophilic factor, recombinant, manufactured protein-free
6 Recruiting Health Related Quality of Life of Youth and Young Adults With Hemophilia A
Condition: Hemophilia A
Intervention:
7 Active, not recruiting Kogenate Liplong Study - BAY 79-4980 Compared to rFVIII-FS in Previously Treated Patients With Severe Hemophilia A
Condition: Hemophilia A
Interventions: Drug: Recomb. Factor VIII (Kogenate FS Liposome, BAY79-4980);   Drug: Recombinant Factor VIII (Kogenate FS, BAY14-2222)
8 Completed Study Comparing Blood Levels of ReFacto and Advante in Hemophilia A
Condition: Hemophilia A
Interventions: Drug: ReFacto;   Drug: Advante
9 Recruiting Trial to Evaluate the Efficacy and Safety of a New Formulation of Kogenate for Hemophilia A
Conditions: Blood Coagulation Disorders;   Hemophilia A
Interventions: Biological: Recombinant Factor VIII (Kogenate PF, BAY81-8973);   Biological: Recombinant Factor VIII (Kogenate FS, BAY14-2222)
10 Recruiting Study of Ataluren (PTC124™) in Hemophilia A and B
Conditions: Hemophilia A;   Hemophilia B
Intervention: Drug: Ataluren (PTC124)
11 Completed Study to Establish Bioequivalence of ReFacto AF (BDDrFVIII) With Advate (FLrFVIII) in Hemophilia A
Condition: Hemophilia A
Interventions: Genetic: ReFacto AF;   Genetic: B-Domain deleted Recombinant Factor VIII;   Genetic: BDDrFVIII
12 Recruiting Safety Study of Alphanate in Previously Treated Patients With Severe Hemophilia A
Condition: Severe Hemophilia A
Intervention: Drug: Alphanate SD
13 Completed Study Evaluating ReFacto® in Hemophilia A Undergoing Major Surgery
Condition: Hemophilia A
Intervention: Drug: ReFacto
14 Terminated Assessment of the Risk of Inhibitor Formation in Previously Treated Patients With Severe Hemophilia A
Condition: Hemophilia A
Intervention: Drug: Kogenate (BAY 14-2222)
15 Recruiting Joint Status in Subjects With Severe Hemophilia A in Relation to Different Treatment Regimens
Condition: Hemophilia A
Intervention: Procedure: No Drug
16 Completed
Has Results 		Study Evaluating B-Domain Deleted Recombinant Factor VIII (BDDrFVIII, ReFacto AF) in Patients With Hemophilia A Undergoing Elective Major Surgery
Condition: Hemophilia A
Intervention: Biological: ReFacto AF
17 Recruiting Trial to Evaluate the Effect of Secondary Prophylaxis With rFVIII Therapy in Severe Hemophilia A Adult Subjects Compared to That of Episodic Treatment. (SPINART)
Condition: Hemophilia A
Intervention: Drug: Recombinant Anti-hemophilic Factor VIII (Kogenate®FS)
18 Recruiting Efficacy and Safety Study of Prophylactic Versus On-Demand Treatment With Feiba NF in Subjects With Hemophilia A or B and a High Titer Inhibitor
Conditions: Hemophilia A;   Hemophilia B;   (High-titer) Factor VIII Inhibitor;   (High-titer) Factor IX Inhibitor
Intervention: Biological: Factor VIII Inhibitor Bypassing Activity (nanofiltered, vapor heat-treated)
19 Recruiting Individually Tailored Prophylaxis in Patients With Severe Hemophilia A
Condition: Hemophilia A
Intervention: Drug: FVIII
20 Completed Pharmacokinetics, Efficacy and Safety Study of IMMUNATE SD (Human Plasma-Derived Coagulation Factor VIII Concentrate) in Hemophilia A Patients
Condition: Hemophilia A
Intervention: Drug: Human Plasma-Derived Coagulation Factor VIII Concentrate (Virus Inactivated by Polysorbate 80 Treatment and Vapor Heat Treatment)

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services